DHR

SELL

Danaher Corporation

Healthcare · Rank #253 · Analyzed Apr 20, 2026

$194.75

Current Price

$151.49

Intrinsic Value

+22.2%

Upside/Downside

2.5/10

Score

2.5/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score2.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueUndervalued by 22.2%

Fair Value Range

Low$49.03

Base (IV)$151.49

High$238.01

Entry Points

Conservative$49.03

Moderate$100.26

Aggressive$151.49

Quality & Moat Breakdown

Return on Equity7.1% → 0/1.0

Debt LevelD/E 37 → 0.5/1.0

Revenue QualityGrowth 3.9%, margin Δ-2.3% +recovery → 1.0/1.0

Moat Strength2.0/5 → 0/1.0

Profit Margins14.7% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.